freedom has been researched along with Glial Cell Tumors in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chumas, P; Fairclough, S; Goodden, J; Maguire, M; Mathew, R | 1 |
| Bc, M; Easwaran, TP; Kingery, K; Lion, A; Raskin, JS; Vortmeyer, AO | 1 |
| Golby, AJ; Valdes, PA | 1 |
3 other study(ies) available for freedom and Glial Cell Tumors
| Article | Year |
|---|---|
Levetiracetam as a first-line antiseizure medication in WHO grade 2 glioma: Time to seizure freedom and rates of treatment failure.
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Freedom; Glioma; Humans; Levetiracetam; Seizures; Treatment Failure; World Health Organization | 2023 |
Seizure freedom from recurrent insular low-grade glioma following laser interstitial thermal therapy.
Topics: Brain Neoplasms; Child; Freedom; Glioma; Humans; Laser Therapy; Lasers; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Seizures; Treatment Outcome | 2020 |
Commentary: Extent of Resection and Residual Tumor Thresholds for Postoperative Total Seizure Freedom in Epileptic Adult Patients Harboring a Supratentorial Diffuse Low-Grade Glioma.
Topics: Adult; Epilepsy; Freedom; Glioma; Humans; Neoplasm, Residual; Seizures | 2019 |